The Risk of Developing Alzheimer’s Disease and Parkinson’s Disease in Patients with Inflammatory Bowel Disease: A Meta-Analysis
Recently, a growing body of research has linked gut microbiota dysbiosis to central nervous system diseases, such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), and has suggested that AD and PD pathology may take its origin from chronic inflammation in the gastrointestinal tract. Thus, th...
Main Authors: | Marta Szandruk-Bender, Benita Wiatrak, Adam Szeląg |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/13/3704 |
Similar Items
-
Association between inflammatory bowel diseases and Parkinson’s disease: systematic review and meta-analysis
by: Yu Zhu, et al.
Published: (2022-01-01) -
Does gut microbiota have an impact on the origin of Alzheimer's and Parkinson's disease? – literature review
by: Izabela Oleksak, et al.
Published: (2024-02-01) -
Increased neutrophils in inflammatory bowel disease accelerate the accumulation of amyloid plaques in the mouse model of Alzheimer’s disease
by: Ryusei Kaneko, et al.
Published: (2023-03-01) -
Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review
by: Rita Polito, et al.
Published: (2020-12-01) -
Gut Microbiota Regulation and Their Implication in the Development of Neurodegenerative Disease
by: Peilin Sun, et al.
Published: (2021-11-01)